446 related articles for article (PubMed ID: 11815495)
21. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
[TBL] [Abstract][Full Text] [Related]
22. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
23. Skin intrinsic fluorescence is associated with hemoglobin A(1c )and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes.
Felipe DL; Hempe JM; Liu S; Matter N; Maynard J; Linares C; Chalew SA
Diabetes Care; 2011 Aug; 34(8):1816-20. PubMed ID: 21636794
[TBL] [Abstract][Full Text] [Related]
24. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
[TBL] [Abstract][Full Text] [Related]
25. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
Karl D; Zhou R; Vlajnic A; Riddle M
Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
[TBL] [Abstract][Full Text] [Related]
26. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
[TBL] [Abstract][Full Text] [Related]
27. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
[TBL] [Abstract][Full Text] [Related]
28. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
29. Derivation & validation of glycosylated haemoglobin (HbA
Mohan A; Reddy SA; Sachan A; Sarma K; Kumar DP; Panchagnula MV; Rao PS; Kumar BS; Krishnaprasanthi P
Indian J Med Res; 2016 Aug; 144(2):220-228. PubMed ID: 27934801
[TBL] [Abstract][Full Text] [Related]
30. Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.
Hoffman RM; Shah JH; Wendel CS; Duckworth WC; Adam KD; Bokhari SU; Dalton C; Murata GH;
Diabetes Care; 2002 Oct; 25(10):1744-8. PubMed ID: 12351471
[TBL] [Abstract][Full Text] [Related]
31. Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.
Peter R; Dunseath G; Luzio SD; Chudleigh R; Choudhury SR; Owens DR
Diabet Med; 2009 Oct; 26(10):974-80. PubMed ID: 19900228
[TBL] [Abstract][Full Text] [Related]
32. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
[TBL] [Abstract][Full Text] [Related]
33. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.
Kilpatrick ES; Rigby AS; Goode K; Atkin SL
Diabetologia; 2007 Dec; 50(12):2553-61. PubMed ID: 17882397
[TBL] [Abstract][Full Text] [Related]
34. Introduction of IFCC reference method for calibration of HbA: implications for clinical care.
Manley S; John WG; Marshall S
Diabet Med; 2004 Jul; 21(7):673-6. PubMed ID: 15209757
[TBL] [Abstract][Full Text] [Related]
35. Effect of HbA1c combined FPG on screening diabetes in health check-up.
Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
[TBL] [Abstract][Full Text] [Related]
36. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
[TBL] [Abstract][Full Text] [Related]
37. Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth.
Vehik K; Cuthbertson D; Boulware D; Beam CA; Rodriguez H; Legault L; Hyytinen M; Rewers MJ; Schatz DA; Krischer JP;
Diabetes Care; 2012 Sep; 35(9):1821-5. PubMed ID: 22699293
[TBL] [Abstract][Full Text] [Related]
38. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
[TBL] [Abstract][Full Text] [Related]
39. Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials.
DeFronzo RA; Stonehouse AH; Han J; Wintle ME
Diabet Med; 2010 Mar; 27(3):309-17. PubMed ID: 20536494
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
Müller N; Kloos C; Frank T; Ristow M; Wolf G; Müller UA
Diabet Med; 2011 Feb; 28(2):223-6. PubMed ID: 21219434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
